CAIRO: Pioneering AI for Personalized Radiation Therapy

CAIRO stands for the Center for Artificial Intelligence in Radiation Oncology. This promising project, initiated by the University Hospital for Radio-Oncology of the Insel Group, launched in January 2025, marking a significant milestone in personalized cancer therapy. The project is led by Prof. Dr. Sarah Brüningk, a leading expert in integrating artificial intelligence (AI) with innovative treatment approaches.

 

What is CAIRO?

CAIRO aims to revolutionize the use of AI in radiation therapy. The project leverages state-of-the-art technologies to provide patients with personalized and more precise treatments. By comprehensively analyzing a wide range of patient data, optimized radiation therapy plans are developed to improve treatment outcomes and reduce side effects.

 

Innovation through Collaboration

The CAIRO project represents a unique partnership of leading institutions aiming to revolutionize radiation therapy together:

The partner organizations are working to break down data silos and create comprehensive data pools. These data form the foundation for the application of artificial intelligence, making treatments more precise, safer, and more efficient. To ensure a seamless data flow, software engineers and data experts collaborate closely. This cooperation guarantees the integration of cutting-edge technology with medical practice, setting new standards in radiation therapy.
 

Focus Areas of CAIRO

  • Personalized Cancer Therapy: Tailored treatment plans based on individual patient data.
  • Reduction of Side Effects: Optimized radiation planning minimizes risks and protects healthy tissue.
  • Efficient Treatment: AI-powered analysis saves time and resources, making radiation therapy even more effective.
  • Integrated Approach: Integration of data from diverse sources for comprehensive patient care.

Our Vision and Mission

At CAIRO, the future of radiation therapy is at the center of our efforts. Our vision is to make cancer treatment faster, more precise, and safer with the help of artificial intelligence.

To achieve this vision, we are focused on three core tasks:

  1. Ensuring Data Quality:
    We provide high-quality, curated data from primary systems to create a reliable foundation for analysis.
  2. Developing Innovative Models:
    Using data science and AI, we develop new approaches that aim to revolutionize radiation therapy.
  3. Clinical Implementation:
    Our developed models are tested and directly implemented in clinical practice to sustainably improve patient care.

Together, we are shaping the future of personalized, patient-centered cancer therapy – grounded in cutting-edge technology and the highest scientific standards.